Top Pharma M&A deals in 2005

June
Matrix Labs decides to acquire the Belgium-based $263-million pharma company Docpharma NV

Torrent Pharma acquires Heumann Pharma GmbH & Co Generica KG, a generic drug company with the Pfizer group at a valuation of $50 mn

October
Jubilant Organosys picks up 100%stake in a US-based CRO, Target Research Sociates Inc, in a $33.5-mn cash deal

Nicholas Piramal India acquires UK's Avecia Pharmaceuticals for a consideration of £9.5 mn

November
Dr Reddy's Labs acquires Roche's API business at its manufacturing site in Cuernavaca, Mexico for $59 mn

Overseas Joint Ventures

February
Strides Arcolab acquires an additional stake of 12.5% at a cost of $6 mn in its JV, Strides Latina

July
Jubilant acquires 64% equity in the US-based generic pharmaceuticals company Trinity Labs Inc and its wholly-owned subsidiary Trigen Labs Inc for $12.25 mn

September
Nicholas Piramal India completes private placement of 7.5 lakh common shares at a price of Canadian $0.80 per share BioSyntech

October
Matrix Labs acquires 43% holding in Explora Laboratories SA, based in Switzerland

November
Hikal enters into a JV by buying a minority stake in one of Sinochem Corporation's subsidiaries in China